The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 234 | 15,328 | SH | SOLE | 15,328 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 387 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,334 | 15,833 | SH | SOLE | 15,833 | 0 | 0 | ||
AKEBIA THERAPEUTICS INC | COM | 00972D105 | 499 | 50,004 | SH | SOLE | 50,004 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,705 | 13,734 | SH | SOLE | 13,734 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 1,052 | 25,552 | SH | SOLE | 25,552 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,390 | 14,112 | SH | SOLE | 14,112 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 1,095 | 5,930 | SH | SOLE | 5,930 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 427 | 133,500 | SH | SOLE | 133,500 | 0 | 0 | ||
BIO TECHNE CORP | COM | 09073M104 | 282 | 1,907 | SH | SOLE | 1,907 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 1,025 | 3,532 | SH | SOLE | 3,532 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 974 | 10,336 | SH | SOLE | 10,336 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 256 | 1,631 | SH | SOLE | 1,631 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 772 | 9,724 | SH | SOLE | 9,724 | 0 | 0 | ||
CHARLES RIV LABS INTL INC | COM | 159864107 | 307 | 2,734 | SH | SOLE | 2,734 | 0 | 0 | ||
CHECKPOINT THERAPEUTICS INC | COM | 162828107 | 336 | 112,760 | SH | SOLE | 112,760 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 591 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
CONTRAFECT CORP | COM | 212326102 | 166 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
EXELIXIS INC | COM | 30161Q104 | 292 | 13,555 | SH | SOLE | 13,555 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 1,153 | 18,423 | SH | SOLE | 18,423 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 301 | 4,251 | SH | SOLE | 4,251 | 0 | 0 | ||
GRIFOLS S A | SP ADR REP B NVT | 398438408 | 268 | 12,442 | SH | SOLE | 12,442 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 1,495 | 5,352 | SH | SOLE | 5,352 | 0 | 0 | ||
INCYTE CORP | COM | 45337C102 | 826 | 12,321 | SH | SOLE | 12,321 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 335 | 3,998 | SH | SOLE | 3,998 | 0 | 0 | ||
INTREXON CORP | COM | 46122T102 | 245 | 17,580 | SH | SOLE | 17,580 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 997 | 23,916 | SH | SOLE | 23,916 | 0 | 0 | ||
IQVIA HLDGS INC | COM | 46266C105 | 278 | 2,789 | SH | SOLE | 2,789 | 0 | 0 | ||
ISHARES TR | NASDAQ BIOTECH | 464287556 | 2,059 | 18,750 | SH | SOLE | 18,750 | 0 | 0 | ||
LOXO ONCOLOGY INC | COM | 548862101 | 1,197 | 6,900 | SH | SOLE | 6,900 | 0 | 0 | ||
MEDICINES CO | COM | 584688105 | 257 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 1,576 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
METTLER TOLEDO INTERNATIONAL | COM | 592688105 | 2,080 | 3,594 | SH | SOLE | 3,594 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 417 | 8,532 | SH | SOLE | 8,532 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 301 | 3,065 | SH | SOLE | 3,065 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | COM | 695127100 | 401 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 204 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
PROGENICS PHARMACEUTICALS IN | COM | 743187106 | 88 | 10,891 | SH | SOLE | 10,891 | 0 | 0 | ||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,123 | 153,846 | SH | SOLE | 153,846 | 0 | 0 | ||
PROSHARES TR | PSHS ULT NASB | 74347R214 | 5,366 | 93,805 | SH | SOLE | 93,805 | 0 | 0 | ||
QIAGEN NV | SHS NEW | N72482123 | 1,183 | 32,720 | SH | SOLE | 32,720 | 0 | 0 | ||
RECRO PHARMA INC | COM | 75629F109 | 63 | 12,615 | SH | SOLE | 12,615 | 0 | 0 | ||
REGENERON PHARMACEUTICALS | COM | 75886F107 | 931 | 2,698 | SH | SOLE | 2,698 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 55 | 33,304 | SH | SOLE | 33,304 | 0 | 0 | ||
SEATTLE GENETICS INC | COM | 812578102 | 1,383 | 20,834 | SH | SOLE | 20,834 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 5,521 | 58,000 | SH | SOLE | 58,000 | 0 | 0 | ||
TESARO INC | COM | 881569107 | 511 | 11,500 | SH | SOLE | 11,500 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 485 | 6,311 | SH | SOLE | 6,311 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 301 | 2,660 | SH | SOLE | 2,660 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,586 | 9,331 | SH | SOLE | 9,331 | 0 | 0 |